Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

Complicated infections such as osteomyelitis, skin and soft tissue infections or endocarditis often require antibiotic therapies that can last up to several weeks. The prolonged hospital length of stay (LOS) leads to a dramatic increase in costs. Single-dose intravenous Dalbavancin is a novel antimi...

Full description

Bibliographic Details
Main Authors: Wilke, Michael, Worf, Kerstin, Preisendörfer, Birgit, Heinlein, Wolfgang, Kast, Tilman, Bodmann, Klaus-Friedrich
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2019-10-01
Series:GMS Infectious Diseases
Subjects:
single-dose intravenous Dalbavancin
health economic model
length of stay
cost savings
Online Access:http://www.egms.de/static/en/journals/id/2019-7/id000043.shtml

Internet

http://www.egms.de/static/en/journals/id/2019-7/id000043.shtml

Similar Items